University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Viread

Viread (tenofovir)

Type of Drug: Nucleotide Reverse Transcriptase Inhibitor

Nucleotide reverse transcriptase inhibitors are also known as NRTIs, nucleotide analogues, or "nukes."

When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.

gray line
transparent gif

Approved adult dosing

one 300 mg tablet, once a day

  • Daily

    Viread 300

    Viread

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Persons with kidney problems may need an adjustment to their dosing schedule, or may need a different drug

Side effects

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Kidney impairment
  • Viread is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif

About | Site Map | Feedback | Subscribe | Donate | Disclaimer

UCSF - Center for HIV Information HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.